STELLARIS PHARMACEUTICALS ApS: Financial statements 2018
CVR: 34708215
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
STELLARIS PHARMACEUTICALS ApS (CVR 34708215) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -70,497 and a net result of DKK -112,692 compared with DKK -78,398 the year before. Equity in the 2018 report amounted to DKK -219,218.
- Gross Profit
- DKK -70,497
- Profit/Loss
- DKK -112,692
- Equity
- DKK -219,218
- Total Assets
- DKK 2,496
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -70 t. | -113 t. | -219 t. | 0 |
| 2017 | - | -45 t. | -78 t. | -107 t. | 0 |
| 2016 | - | - | -118 t. | -575 t. | - |
| 2015 | - | - | -127 t. | -457 t. | - |
| 2014 | - | - | -384 t. | -330 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2017. Gross profit came to DKK -45,200, and the net result was DKK -78,398.
About STELLARIS PHARMACEUTICALS ApS
STELLARIS PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Birgit Ter-Borch Gram Lilienfeldt Schjoldager. The company is owned by Ranoda Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -475,262 and a net result of DKK -594,882 compared with DKK -486,941 the year before. Equity in the 2025 report amounted to DKK -3,565,816.